Evidence map›Paper›PMID 24597516›Full record

ArticleAIDS research and human retroviruses2014

The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties.

Ivo C Lorenz, Hanh T Nguyen, Marina Kemelman, Ross W Lindsay, Maoli Yuan, Kevin J Wright, Heather Arendt, Jaap Willem Back, Joanne DeStefano, Simon Hoffenberg and 5 more

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Protein expression/secretion boost by a novel unique 21-mer cis-regulatory motif (Exin21) via mRNA stabilization.Molecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Ivo C Lorenz1 The International AIDS Vaccine Initiative, AIDS Vaccine Design and Development Laboratory , Brooklyn, New York.
Hanh T Nguyen
Marina Kemelman
Ross W Lindsay
Maoli Yuan
Kevin J Wright
Heather Arendt
Jaap Willem Back
Joanne DeStefano
Simon Hoffenberg
Gavin Morrow
Christy K Jurgens
Sanjay K Phogat
Timothy J Zamb
Christopher L Parks
Pepscan (Netherlands) · NL

Funding

Using VSV Vectors to Display and Evolve Novel HIV Envelope ImmunogensR01AI084840 · NIAID · INTERNATIONAL AIDS VACCINE INITIATIVE · PI LORENZ, IVO C, PARKS, CHRISTOPHER · 2009 to 2013
$2.0M
NIAID NIH HHS R01 AI084840NIAID NIH HHS R01AI084840
6 · The paper itself

Abstract

The structure of the HIV-1 envelope membrane-proximal external region (MPER) is influenced by its association with the lipid bilayer on the surface of virus particles and infected cells. To develop a replicating vaccine vector displaying MPER sequences in association with membrane, Env epitopes recognized by the broadly neutralizing antibodies 2F5, 4E10, or both were grafted into the membrane-proximal stem region of the vesicular stomatitis virus (VSV) glycoprotein (G). VSV encoding functional G-MPER chimeras based on G from the Indiana or New Jersey serotype propagated efficiently, although grafting of both epitopes (G-2F5-4E10) modestly reduced replication and resulted in the acquisition of one to two adaptive mutations in the grafted MPER sequence. Monoclonal antibodies 2F5 and 4E10 efficiently neutralized VSV G-MPER vectors and bound to virus particles in solution, indicating that the epitopes were accessible in the preattachment form of the G-MPER chimeras. Overall, our results showed that the HIV Env MPER could functionally substitute for the VSV G-stem region implying that both perform similar functions even though they are from unrelated viruses. Furthermore, we found that the MPER sequence grafts induced low but detectable MPER-specific antibody responses in rabbits vaccinated with live VSV, although additional vector and immunogen modifications or use of a heterologous prime-boost vaccination regimen will be required to increase the magnitude of the immune response.

Indexed as

AnimalsAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusFemaleHIV AntibodiesMembrane GlycoproteinsRabbitsRecombinant ProteinsVesiculovirusViral Envelope ProteinsVirus ReplicationAntibodies, Neutralizingenv Gene Products, Human Immunodeficiency VirusG protein, vesicular stomatitis virusHIV AntibodiesMembrane GlycoproteinsRecombinant ProteinsViral Envelope Proteins

Identifiers

PMID24597516
PMCPMC4208592
OpenAlexW228585438

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.